NASDAQ:CORT

Corcept Therapeutics Stock News

etoro logo Buy CORT
*Your capital is at risk
$72.65
+1.45 (+2.04%)
At Close: Jun 03, 2026
Corcept Therapeutics (NASDAQ:CORT) was upgraded by analysts at BidaskClub from a “hold” rating to a “buy” rating in a research note issued to investors on Tuesday, BidAskClub reports. Several
MENLO PARK, Calif., April 27, 2020 -- Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report first quarter financial results and provide a corporate.
Does Corcept Therapeutics (CORT) have what it takes to be a top stock pick for momentum investors? Let's find out.
Does Corcept Therapeutics (CORT) have what it takes to be a top stock pick for momentum investors? Let's find out.
As a general rule, we think profitable companies are less risky than companies that lose money. However, sometimes...
Bank of America Corp DE trimmed its holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT) by 57.7% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange C
Corcept Therapeutics Incorporated (NASDAQ:CORT) saw a large decline in short interest in the month of March. As of March 31st, there was short interest totalling 20,830,000 shares, a decline of 5.7% f
Like a puppy chasing its tail, some new investors often chase 'the next big thing', even if that means buying 'story...
Assenagon Asset Management S.A. bought a new position in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) in the first quarter, according to its most recent Form 13F filing with the Securitie
Valuation metrics in the healthcare sector. Evolution since last month. A list of stocks looking cheap in their industries.
Louisiana State Employees Retirement System cut its stake in Corcept Therapeutics Incorporated (NASDAQ:CORT) by 19.4% in the first quarter, according to the company in its most recent filing with the
Corcept Therapeutics (NASDAQ:CORT) was downgraded by BidaskClub from a “buy” rating to a “hold” rating in a report released on Friday, BidAskClub reports. Other equities analysts also recently
Brokerages predict that Corcept Therapeutics Incorporated (NASDAQ:CORT) will announce $86.87 million in sales for the current quarter, according to Zacks. Three analysts have issued estimates for Corc

5 Growth ETFs & Stocks Set To Flourish In Spring

05:02pm, Wednesday, 15'th Apr 2020
Investors should reposition their portfolio for more exposure to the growth space to obtain a nice momentum play. For them, here are five ETFs and stocks that are ready to bloom this spring.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE